Deborah Cooper

As Canada faces a monumental energy shift, Toronto Hydro CEO Jana Mosley takes the helm at Electricity Canada, tasked with guiding the nation’s grid modernization.

Cardinal Infrastructure's plan to raise capital caused a stock dip, but it's a strategic move to fuel aggressive expansion in a booming market.

Eleven partners at SBSB were named to Lawdragon's 'Next Gen' list. It's not just an award; it's a look into the future of legal expertise and trust.

The bubble tea giant is launching 'Select,' a premium concept focused on craft and tradition. Is it a genuine cultural evolution or a savvy business pivot?

A new 'Buy' rating for geothermal pioneer Arverne signals rising faith in Earth's dual power: clean heat and the lithium vital for our green future.

A building’s success hinges on more than steel and glass. It requires a deep-seated trust in its builders, especially in the complex world of design-build.

As Teamshares hits the public market, its radical model of buying small businesses for their employees challenges the PE playbook. Is this the future of SME succession?

As America plans its 250th birthday, one company is using canine science and digital media to address the hidden stress the celebration causes our pets.

Novarc Technologies' new AI suite promises to give robots the 'perception and cognition' of a master welder, tackling a skilled labor gap threatening global industry.

OfferUp's new campaign spotlights how users are turning local buys into thriving businesses, revealing the hidden economic engine of the recommerce market.

For the third year, HRCI proves a top workplace is built on trust, not proximity. How does a remote-first HR leader set the standard for the future of work?

A landmark partnership in Oklahoma brings Direct Primary Care to ACA plans, using tech to restore the human connection at the heart of medicine. Is this the future?

Footballer Cole Palmer's new premium ice line is more than a celebrity endorsement; it's a case study in modern branding, instant commerce, and public trust.

With a seasoned regulatory expert at the helm, Arletta Pharma is betting on its dual-action therapy, Lybrido, to transform the underserved FSIAD market.

A Sino-European venture is building the Kingdom's first world-class battery factory, a pivotal move to fuel Vision 2030 and redefine its energy future.

Behind the scenes of major infrastructure projects, an industry's strategic recalibration around data, policy, and people is quietly reinforcing public trust.

How a sparkling water brand and a grocery chain are humanizing corporate giving by empowering communities to support veterans, one service dog at a time.

A new survey reveals a startling trend: affluent Americans are planning their escape. We dig into the data, from war fears to tax woes, and the "Golden Visas" they're using.

Cabot Corporation's sixth EcoVadis Platinum rating is more than an award; it highlights a crucial evolution in corporate accountability, ethics, and trust.

A new drug from Cambrian Bio shows promise in activating a key metabolic switch. This could lead to treatments that burn fat while preserving muscle mass.